The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Salivary Gland Infection Market During 2026–2030?
The salivary gland infection market size has experienced robust expansion in recent years. It is projected to expand from $4.45 billion in 2025 to $4.81 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.1%. Historically, this growth has been driven by the increasing incidence of bacterial and viral salivary infections, improved access to diagnostic imaging, the availability of broad-spectrum antibiotics, the expansion of hospital-based ENT services, and a rising clinical awareness of gland disorders.
The salivary gland infection market is projected to experience substantial expansion over the coming years. It is anticipated to achieve a valuation of $6.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is propelled by factors such as a heightened demand for precise diagnostic capabilities, increased funding for ENT diagnostic equipment, the proliferation of outpatient diagnostic services, a greater emphasis on treatment approaches centered around the patient, and improved integration of imaging and laboratory diagnostics. Key developments expected during this period include an increased utilization of sophisticated imaging diagnostics, a rise in the adoption of targeted antibiotic treatments, an intensified focus on identifying infections early, the expansion of less invasive therapeutic methods, and a stronger commitment to holistic diagnostic processes.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp
Which Major Factors Are Driving The Expansion Of The Salivary Gland Infection Market?
An anticipated expansion of the salivary gland infections market is linked to an increase in oral health problems. Such problems encompass conditions like tooth decay, gum diseases, and various other mouth-related ailments. The escalation of these oral health concerns is fueled by poor oral hygiene practices, detrimental dietary habits, and insufficient access to dental care. This surge in oral health issues elevates the likelihood of salivary gland infections, primarily by encouraging bacterial proliferation and obstructions within the salivary ducts. A notable example is the data from May 2024, where the National Health Service (NHS), a UK-based government body, reported 32.5 million dental treatments in 2022-23, marking a 23.2% rise from the prior year. Consequently, the increasing prevalence of oral health challenges is a key factor propelling the expansion of the salivary gland infections market.
Salivary Gland Infection Market Driver: Increased Demand for Minimally Invasive Surgery Driving Market Growth Amidst Preference for Quicker and Safer Treatments
How Are The Various Segments Of The Salivary Gland Infection Market Categorized?
The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User
Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
What Trends Are Projected To Affect The Salivary Gland Infection Market?
Leading companies in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to enhance treatment outcomes, accelerate patient recovery, and improve overall healthcare efficiency. These minimally invasive procedures utilize smaller incisions and specialized tools, leading to reduced tissue damage and promoting quicker healing. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, inaugurated the Amrita Centre for minimally invasive salivary gland surgery. This center offers a groundbreaking endoscopic treatment for salivary disorders, minimizing the necessity for surgery and preserving glandular function. A two-day workshop showcasing expert demonstrations marked the launch.
Which Major Firms Influence Developments In The Salivary Gland Infection Market?
Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc
Read the full salivary gland infection market report here:
https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report
Which Region Currently Holds The Largest Share Of The Salivary Gland Infection Market?
North America was the largest region in the salivary gland infection market in 2025. The regions covered in the salivary gland infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Salivary Gland Infection Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21281&type=smp
Browse Through More Reports Similar to the Global Salivary Gland Infection Market 2026, By The Business Research Company
Covid 19 Saliva Screening Test Potential Global Market Report
Oral Hygiene Global Market Report
https://www.thebusinessresearchcompany.com/report/oral-hygiene-global-market-report
Ear Infection Global Market Report
https://www.thebusinessresearchcompany.com/report/ear-infection-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model